![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 29, 22568-22573, July 21, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,
§,
§,
¶
From the Telomerase is a specialized reverse transcriptase
that catalyzes elongation of the telomeric tandem repeat, TTAGGG, by
addition of this sequence to the ends of existing telomeres. Human
telomerase reverse transcriptase (hTERT) has been identified as a
catalytic enzyme involved in telomere elongation that requires
telomerase RNA, human telomerase RNA component (hTR), as an RNA
template. We established a new method to express and purify soluble
insect-expressed recombinant hTERT. The partially purified FLAG-hTERT
retained the catalytic activity of telomerase in a complementation
assay in vitro to exhibit telomerase activity in
telomerase-negative TIG3 cell extract and in a reconstitution assay
with FLAG-hTERT and purified hTR in vitro. FLAG-hTERT
(D712A) with a mutation in the VDV motif exhibited no telomerase
activity, confirming the authentic catalytic activity of FLAG-hTERT.
The reconstituted complex of FLAG-hTERT and hTR in vitro
was detected by electrophoretic mobility shift assay, and its
activity was stimulated by more than 30-fold by TIG3 cell extract. This
suggested that some cellular component(s) in the extract facilitated
the reconstituted telomerase activity in vitro.
Geldanamycin had no effect on the reconstituted activity but partially
reduced the stimulated activity of the reconstituted telomerase
by the TIG3 cell extract, suggesting that Hsp90 may contribute to
the stimulatory effect of the cellular components.
Department of Molecular Biology, Division of
Molecular Oncology, Cancer Research Institute and the
§ First Department of Internal Medicine, Medical School,
Kanazawa University, Kanazawa 920-0934, Japan
This article has been cited by other articles:
![]() |
H. Mizuno, S. Khurts, T. Seki, Y. Hirota, S. Kaneko, and S. Murakami Human Telomerase Exists in Two Distinct Active Complexes In Vivo J. Biochem., May 1, 2007; 141(5): 641 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Compton, L. W. Elmore, K. Haydu, C. K. Jackson-Cook, and S. E. Holt Induction of Nitric Oxide Synthase-Dependent Telomere Shortening after Functional Inhibition of Hsp90 in Human Tumor Cells Mol. Cell. Biol., February 15, 2006; 26(4): 1452 - 1462. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Jacobs, E. R. Podell, D. S. Wuttke, and T. R. Cech Soluble domains of telomerase reverse transcriptase identified by high-throughput screening Protein Sci., August 1, 2005; 14(8): 2051 - 2058. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khurts, K. Masutomi, L. Delgermaa, K. Arai, N. Oishi, H. Mizuno, N. Hayashi, W. C. Hahn, and S. Murakami Nucleolin Interacts with Telomerase J. Biol. Chem., December 3, 2004; 279(49): 51508 - 51515. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Oulton and L. Harrington A Human Telomerase-associated Nuclease Mol. Biol. Cell, July 1, 2004; 15(7): 3244 - 3256. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Bryan, K. J. Goodrich, and T. R. Cech Tetrahymena Telomerase Is Active as a Monomer Mol. Biol. Cell, December 1, 2003; 14(12): 4794 - 4804. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Boltze, J. Mundschenk, N. Unger, R. Schneider-Stock, B. Peters, C. Mawrin, C. Hoang-Vu, A. Roessner, and H. Lehnert Expression Profile of the Telomeric Complex Discriminates between Benign and Malignant Pheochromocytoma J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4280 - 4286. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kyo, K. Masutomi, Y. Maida, T. Kanaya, N. Yatabe, M. Nakamura, M. Tanaka, M. Takarada, I. Sugawara, S. Murakami, et al. Significance of Immunological Detection of Human Telomerase Reverse Transcriptase: Re-Evaluation of Expression and Localization of Human Telomerase Reverse Transcriptase Am. J. Pathol., September 1, 2003; 163(3): 859 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Arai, K. Masutomi, S. Khurts, S. Kaneko, K. Kobayashi, and S. Murakami Two Independent Regions of Human Telomerase Reverse Transcriptase Are Important for Its Oligomerization and Telomerase Activity J. Biol. Chem., March 1, 2002; 277(10): 8538 - 8544. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Mergny, J.-F. Riou, P. Mailliet, M.-P. Teulade-Fichou, and E. Gilson Natural and pharmacological regulation of telomerase Nucleic Acids Res., February 15, 2002; 30(4): 839 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N. Armbruster, S. S. R. Banik, C. Guo, A. C. Smith, and C. M. Counter N-Terminal Domains of the Human Telomerase Catalytic Subunit Required for Enzyme Activity in Vivo Mol. Cell. Biol., November 15, 2001; 21(22): 7775 - 7786. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. X. Mason, C. Autexier, and C. W. Greider Tetrahymena proteins p80 and p95 are not core telomerase components PNAS, October 5, 2001; (2001) 221456398. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bachand, I. Triki, and C. Autexier Human telomerase RNA-protein interactions Nucleic Acids Res., August 15, 2001; 29(16): 3385 - 3393. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bachand and C. Autexier Functional Regions of Human Telomerase Reverse Transcriptase and Human Telomerase RNA Required for Telomerase Activity and RNA-Protein Interactions Mol. Cell. Biol., March 1, 2001; 21(5): 1888 - 1897. [Abstract] [Full Text] |
||||
![]() |
H. L. Forsythe, J. L. Jarvis, J. W. Turner, L. W. Elmore, and S. E. Holt Stable Association of hsp90 and p23, but Not hsp70, with Active Human Telomerase J. Biol. Chem., May 4, 2001; 276(19): 15571 - 15574. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. X. Mason, C. Autexier, and C. W. Greider Tetrahymena proteins p80 and p95 are not core telomerase components PNAS, October 23, 2001; 98(22): 12368 - 12373. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |